Schizophrenia 2 -Preclinical

[P159] Heterocyclic Cathinones as Potential Schizophrenia Therapeutics

*Hana Walaska¹, Michal Maryska^1,2, Lucie Svobodova¹, Wim Dehaen³, Martin Kuchar^1,2 (1. Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, Faculty of Food and Biochemical Technology, UCT Prague, Technická 5, 16628 Prague, Czech Republic, 2. National Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic, 3. CZ-OPENSCREEN: National Infrastructure for Chemical Biology, Department of Informatics and Chemistry, Faculty of Chemical Technology, UCT Prague, Technická 5, 16628 Prague, Czech Republic)

Keywords:Schizophrenia, KAT inhibitor, Drug design, Heterocyclic Cathinones